These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25339488)
1. Biomarkers and heart disease. Sun RR; Lu L; Liu M; Cao Y; Li XC; Liu H; Wang J; Zhang PY Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2927-35. PubMed ID: 25339488 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure. Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692 [TBL] [Abstract][Full Text] [Related]
4. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients. Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184 [TBL] [Abstract][Full Text] [Related]
5. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes. Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866 [TBL] [Abstract][Full Text] [Related]
6. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure. Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975 [TBL] [Abstract][Full Text] [Related]
7. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708 [TBL] [Abstract][Full Text] [Related]
8. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort. Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008 [TBL] [Abstract][Full Text] [Related]
9. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study. Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681 [TBL] [Abstract][Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
11. Current Use of Cardiac Biomarkers in Various Heart Conditions. Khan S; Rasool ST Endocr Metab Immune Disord Drug Targets; 2021; 21(6):980-993. PubMed ID: 32867665 [TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides in heart failure and acute coronary syndrome. Gaggin HK; Januzzi JL Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis. Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664 [TBL] [Abstract][Full Text] [Related]
14. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure. Alehagen U; Dahlström U; Rehfeld JF; Goetze JP J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836 [TBL] [Abstract][Full Text] [Related]
16. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Ibrahim N; Januzzi JL Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers for heart failure: small molecules with high clinical relevance. Magnussen C; Blankenberg S J Intern Med; 2018 Jun; 283(6):530-543. PubMed ID: 29682806 [TBL] [Abstract][Full Text] [Related]